Elite Trades From Anywhere

$100 Off Your First Year

Claim Now
Today, 6:05 AMRockwell Medical announces a 1-for-10 reverse stock split effective July 1, 2026, aiming to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.
Index
-
Market Cap
23.38M
Enterprise Value
13.88M
Income
-5.40M
Sales
67.68M
Book/sh
0.91
Cash/sh
0.61
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
157
IPO
Jan 27, 1998
P/E
-
Forward P/E
-
PEG
-
P/S
0.35
P/B
0.65
P/C
0.98
P/FCF
13.29
EV/EBITDA
-
EV/Sales
0.21
Quick Ratio
3.43
Current Ratio
3.74
Debt/Eq
0.40
LT Debt/Eq
0.33
Option/Short
Yes / Yes
EPS (ttm)
-0.15
EPS next Y
-0.01
EPS next Q
-0.03
EPS this Y
40.00%
EPS next Y
94.44%
EPS next 5Y
-
EPS past 3/5Y
56.86% 49.20%
Sales past 3/5Y
-1.65% 2.17%
EPS Y/Y TTM
-1056.69%
Sales Y/Y TTM
-30.75%
EPS Q/Q
8.33%
Sales Q/Q
-8.34%
Insider Own
11.63%
Insider Trans
-0.08%
Inst Own
10.08%
Inst Trans
0.76%
ROA
-9.70%
ROE
-16.04%
ROIC
-11.36%
Gross Margin
17.06%
Oper. Margin
-7.11%
Profit Margin
-7.98%
SMA20
-10.57%
SMA50
-22.53%
SMA200
-38.80%
Trades
Shs Outstand
39.47M
Shs Float
34.88M
52W High
2.10 -71.80%
52W Low
0.60 -1.69%
Volatility
4.97% 5.93%
ATR (14)
0.04
RSI (14)
31.93
Beta
1.59
Rel Volume
6.76
Avg Volume
265.74K
Volume
1,183,555
Perf Week
-11.49%
Perf Month
-21.77%
Perf Quarter
-31.94%
Perf Half Y
-26.81%
Perf YTD
-28.94%
Perf Year
-25.22%
Perf 3Y
-86.98%
Perf 5Y
-94.27%
Perf 10Y
-99.31%
Prev Close
0.65
Price
0.59
Change
-9.02%
Date Action Analyst Rating Change Price Target Change
Nov-14-24Initiated Rodman & Renshaw Buy $5
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Today 07:40AM
06:00AM
May-14-26 06:00AM
May-08-26 08:30AM
May-07-26 06:09AM
06:00AM Loading…
06:00AM
Apr-09-26 06:00AM
Mar-31-26 08:07PM
08:06PM
Mar-26-26 03:00PM
01:14PM
06:15AM
06:00AM
Feb-26-26 06:00AM
Feb-16-26 08:55AM
09:40AM Loading…
Feb-13-26 09:40AM
Feb-12-26 06:00AM
Jan-28-26 12:00PM
09:40AM
08:55AM
Jan-20-26 10:18AM
06:00AM
Jan-12-26 06:00AM
Jan-05-26 06:00AM
Nov-18-25 06:00AM
Nov-12-25 02:03PM
07:10AM
06:09AM
06:00AM
Nov-11-25 06:00AM
06:15PM Loading…
Nov-06-25 06:15PM
Oct-28-25 06:00AM
Oct-23-25 06:00AM
Oct-15-25 06:00AM
Sep-29-25 12:00PM
Sep-10-25 08:50AM
Sep-02-25 10:30AM
Aug-25-25 08:50AM
Aug-14-25 07:20AM
06:20AM
06:00AM
Aug-08-25 08:15AM
Aug-07-25 05:35PM
Aug-05-25 06:30PM
Jul-17-25 06:00AM
Jul-08-25 06:00AM
May-13-25 03:03AM
May-12-25 10:07PM
07:15AM
06:11AM
06:00AM
May-08-25 09:20AM
Apr-14-25 06:00AM
Mar-21-25 07:08AM
03:02AM
Mar-20-25 11:44PM
09:37AM
09:36AM
07:10AM
06:18AM
06:00AM
Mar-19-25 06:00PM
Mar-11-25 06:00AM
Feb-27-25 06:00AM
Feb-20-25 06:00AM
Feb-04-25 06:00AM
Dec-17-24 07:51AM
06:00AM
Dec-13-24 03:48PM
12:11PM
Dec-12-24 06:00AM
Dec-05-24 06:00AM
Nov-19-24 06:00AM
Nov-13-24 02:06AM
Nov-12-24 10:01PM
07:10AM
06:12AM
06:00AM
Nov-11-24 07:21AM
Nov-08-24 07:06AM
06:00AM
Oct-17-24 12:00PM
Oct-14-24 06:00AM
Oct-09-24 05:33PM
Sep-20-24 09:15AM
Sep-18-24 06:00AM
Sep-09-24 12:00PM
08:50AM
06:00AM
Sep-04-24 09:15AM
Sep-03-24 06:00AM
Aug-19-24 09:15AM
Aug-15-24 08:50AM
Aug-08-24 07:15AM
06:13AM
06:00AM
Aug-07-24 06:00AM
Jul-15-24 06:45AM
Jul-11-24 06:00AM
May-30-24 06:00AM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
PresidentDr. Mark Strobeck Ph.D.
Senior VP & CFOMr. Jesse Neri
Executive VPMs. Megan C. Timmins
Senior VP & COOMs. Heather H. Hunter
Controller & Principal Accounting OfficerMr. Nicholas Fanslau
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hunter HeatherChief Operating OfficerJan 02 '26Sale0.842,8682,396132,523Jan 05 04:15 PM
Neri JesseSVP and CFOJan 02 '26Sale0.84886740124,842Jan 05 04:13 PM
Neri JesseOfficerJan 02 '26Proposed Sale0.80886712Jan 05 09:38 AM
Hunter HeatherOfficerJan 02 '26Proposed Sale0.812,8682,318Jan 02 04:40 PM
COOPER JOHN GDirectorNov 18 '25Sale0.875,0794,419140,372Nov 18 04:26 PM
COOPER JOHN GDirectorNov 18 '25Proposed Sale0.905,0794,572Nov 18 09:54 AM
Hunter HeatherSVP, Chief Operating OfficerOct 01 '25Sale1.192,8683,413135,391Oct 08 07:48 PM
Neri JesseOfficerOct 01 '25Proposed Sale1.158861,017Oct 01 04:27 PM
Chole TimothySVP and CCOOct 01 '25Sale1.192,8683,413125,299Oct 01 04:24 PM
Neri JesseSVP and CFOOct 01 '25Sale1.198861,054125,728Oct 01 04:23 PM
Strobeck MarkPresident and CEOOct 01 '25Sale1.196,9268,242330,826Oct 01 04:22 PM
Strobeck MarkOfficerOct 01 '25Proposed Sale1.166,9268,028Oct 01 04:20 PM
Chole TimothyOfficerOct 01 '25Proposed Sale1.162,8683,321Oct 01 01:37 PM
Chole TimothySVP and CCOJul 01 '25Sale0.822,8682,352128,167Jul 02 05:22 PM
Neri JesseSVP and CFOJul 01 '25Sale0.82886727126,614Jul 02 05:20 PM
Strobeck MarkPresident and CEOJul 01 '25Sale0.826,9265,679337,752Jul 02 05:17 PM
Strobeck MarkOfficerJul 01 '25Proposed Sale0.806,9265,536Jul 01 01:12 PM
Chole TimothyOfficerJul 01 '25Proposed Sale0.792,8682,271Jul 01 01:07 PM
Neri JesseOfficerJul 01 '25Proposed Sale0.79886697Jul 01 01:03 PM